103 related articles for article (PubMed ID: 11478692)
1. Location and incidence of chromosome and chromatid breaks in patients with Hodgkin's disease or testicular tumors.
Bilban-Jakopin C; Bilban M
Neoplasma; 2001; 48(2):122-6. PubMed ID: 11478692
[TBL] [Abstract][Full Text] [Related]
2. High incidence of chromosome aberrations after radiochemotherapy for Hodgkin's disease: a report of a case and a review of the literature.
Lalić H; Radosević-Stasić B; Volavsek C
Folia Biol (Praha); 2001; 47(3):101-5. PubMed ID: 11409315
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal changes in somatic cells in seminoma patients after treatment with ionizing radiation or cytostatics.
Bilban-Jakopin C
Neoplasma; 2000; 47(1):48-55. PubMed ID: 10870687
[TBL] [Abstract][Full Text] [Related]
4. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients.
Tempest HG; Ko E; Chan P; Robaire B; Rademaker A; Martin RH
Hum Reprod; 2008 Feb; 23(2):251-8. PubMed ID: 18083744
[TBL] [Abstract][Full Text] [Related]
5. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
6. Chromosomes in Hodgkin's disease--analysis of involved lymph nodes.
Ankathil R; Vijayakumar T; Pillai GR; Nair MK
Neoplasma; 1992; 39(4):245-8. PubMed ID: 1436237
[TBL] [Abstract][Full Text] [Related]
7. Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy.
Krasin MJ; Rai SN; Kun LE; Merchant TE; Metzger ML; Kaste SC; Howard SC; Hudson MM
J Clin Oncol; 2005 Nov; 23(33):8406-13. PubMed ID: 16293871
[TBL] [Abstract][Full Text] [Related]
8. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
9. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
10. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
[TBL] [Abstract][Full Text] [Related]
11. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
12. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract][Full Text] [Related]
13. Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group.
Bamias A; Aravantinos G; Deliveliotis C; Thanos A; Klouvas G; Antoniou N; Poulias I; Makatsoris T; Samantas E; Dimopoulos MA
Urology; 2007 Dec; 70(6):1179-83. PubMed ID: 18158042
[TBL] [Abstract][Full Text] [Related]
14. [The clinical treatment analysis of 176 cases of testicular germ cell tumor].
Zhang P; Zeng H; Lu YP; Yuan Y; Li H
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):237-9. PubMed ID: 16597041
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities.
Miyake H; Muramaki M; Eto H; Kamidono S; Hara I
Oncol Rep; 2004 Oct; 12(4):867-70. PubMed ID: 15375514
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients.
Strom SS; Hess KR; Sigurdson AJ; Spitz MR; Liang JC
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):291-3. PubMed ID: 9107435
[TBL] [Abstract][Full Text] [Related]
18. Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy.
Müller I; Geinitz H; Braselmann H; Baumgartner A; Fasan A; Thamm R; Molls M; Meineke V; Zitzelsberger H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1214-20. PubMed ID: 16253775
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
20. [Long-term results of multimodality therapy of testicular germ cell tumor].
Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
